UNSPSC 85681924: Supplement left maxilla with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left maxilla with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NUS47Z

UNSPSC 85681924 Supplement left maxilla with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows a significant mismatch between its nominal scope—a highly specific surgical procedure involving maxillofacial tissue grafting—and the actual work state and local governments are soliciting under it. The five most recent opportunities tagged to this code do not include any maxillofacial or tissue-grafting procurement; instead, they span inmate medical and pharmacy services, pharmacy benefit management, virtual primary care and urgent care, peer support services for mental health workers, and fire department medical direction. The code appears to be a miscategorization or data error in how state and local procurement notices are being tagged. State and local healthcare procurement activity—particularly county correctional healthcare, employee health plan administration, and virtual care services—occurs regularly under various healthcare-related codes, but this specific Commodity code does not reflect actual purchasing patterns in the state and local market.

The source provides no evidence of recent state and local procurement activity under UNSPSC 85681924 that aligns with maxillofacial surgery or autologous tissue supplementation. A business development professional evaluating this code should confirm the correct UNSPSC classification for their intended service line rather than relying on this Commodity code's tagging in state and local notices.